NASDAQ:ELGX Endologix (ELGX) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.07▼$0.0850-Day Range$0.02▼$0.2252-Week Range$0.22▼$7.10Volume85,372 shsAverage Volume1.28 million shsMarket Capitalization$1.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Endologix alerts: Email Address Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Endologix Stock (NASDAQ:ELGX)Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.Read More Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. ELGX Stock News HeadlinesOctober 20, 2022 | businesswire.comEndovascular Aneurysm Repair Global Market Report 2022: Advantages Over Open Heart Surgery Driving Adoption & Growth - ResearchAndMarkets.com - Business WireOctober 19, 2022 | finance.yahoo.comVascular Grafts Market to record USD 1.55 Bn incremental growth; Market structure to be fragmented -- Technavio - Yahoo FinanceJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.October 14, 2022 | finance.yahoo.comEndovascular Aneurysm Repair Global Market Report 2022: Next Generation Technologies Are Here, Shaping Future Growth Opportunities - Yahoo FinanceOctober 10, 2022 | businesswire.comEndologix Submits Premarket Approval (PMA) Application to FDA for the DETOURTM System. - businesswire.comSeptember 19, 2022 | prnewswire.comAortic Stent Grafts Market to record USD 781.72 Mn growth -- Driven by rising incidence of aortic aneurysms - PR NewswireSeptember 19, 2022 | globenewswire.comPeripheral Vascular Devices Market Size Worth US$ 16.46 Billion by 2030 at 6.3% CAGR, COVID-19 Impact and Global Analysis by Growth Plus Reports - GlobeNewswireAugust 18, 2022 | globenewswire.comEndovascular Aneurysm Repair Emerging as Frontrunner with Over Half Revenue Share of Vascular Grafts, Finds Fact.MR - GlobeNewswireJuly 26, 2024 | Colonial Metals (Ad)Collapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.August 8, 2022 | finance.yahoo.comGlobal Endovascular Devices Market valued at $5.4 billion in 2021, is expected to witness a decent growth rate of 5% by 2026 – Providing Hope to Patients Suffering from Vascular Diseases - Yahoo FinanceAugust 8, 2022 | uk.finance.yahoo.comGlobal Endovascular Devices Market valued at $5.4 billion in 2021, is expected to witness a decent growth rate of 5% by 2026 – Providing Hope to Patients Suffering from Vascular Diseases - Yahoo Finance UKAugust 4, 2022 | businesswire.comEndologix Receives CE Mark Certification under EU-MDR for AFX®2 Endovascular AAA System - Business WireJune 29, 2022 | finance.yahoo.comThe Global Vascular Stents Market to Surge at a CAGR of 7.90% by 2027 | DelveInsight - Yahoo FinanceJune 29, 2022 | finance.yahoo.comGlobal Endovascular Aneurysm Repair Market Size, Share & Industry Trends Analysis Report By Indication, By Product, By Site, By Anatomy, By Regional Outlook and Forecast, 2022 - 2028 - Yahoo FinanceJune 23, 2022 | finance.yahoo.comVascular Stent Market Research Report by Type, Material, Mode of Delivery, Product, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Yahoo FinanceMay 26, 2022 | finance.yahoo.comVascular Grafts Global Market Report 2022 - Yahoo FinanceMay 2, 2022 | finance.yahoo.comThe Abdominal Aortic Aneurysm Market to Boost at a CAGR of 3% During the Study Period (2019-32), Assesses DelveInsight - Yahoo FinanceApril 6, 2022 | finance.yahoo.comAllego® Expands Its Customer Base in the Age of Virtual Selling - Yahoo FinanceSee More Headlines Receive ELGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endologix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/11/2020Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:ELGX CUSIP29266S10 CIK1013606 Webwww.endologix.com Phone949-595-7200FaxN/AEmployees528Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-64,760,000.00 Net Margins-44.65% Pretax MarginN/A Return on Equity-63.96% Return on Assets-13.26% Debt Debt-to-Equity Ratio0.29 Current Ratio0.39 Quick Ratio0.28 Sales & Book Value Annual Sales$143.37 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value$3.56 per share Price / Book0.02Miscellaneous Outstanding Shares19,172,000Free FloatN/AMarket Cap$1.41 million OptionableOptionable Beta0.73 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. John Onopchenko (Age 60)CEO & Director Mr. Vaseem Mahboob (Age 50)Chief Financial Officer Dr. Michael V. Chobotov (Age 58)Chief Technology Officer Mr. Jeffrey S. BrownChief Operations OfficerMr. Jeremy B. Hayden (Age 49)Gen. Counsel Key CompetitorsWest Pharmaceutical ServicesNYSE:WSTAlign TechnologyNASDAQ:ALGNCooper CompaniesNASDAQ:COODENTSPLY SIRONANASDAQ:XRAYMerit Medical SystemsNASDAQ:MMSIView All Competitors ELGX Stock Analysis - Frequently Asked Questions How were Endologix's earnings last quarter? Endologix, Inc. (NASDAQ:ELGX) released its earnings results on Monday, May, 11th. The medical instruments supplier reported ($0.80) EPS for the quarter, missing analysts' consensus estimates of ($0.67) by $0.13. The medical instruments supplier earned $28.51 million during the quarter, compared to analysts' expectations of $28.50 million. Endologix had a negative net margin of 44.65% and a negative trailing twelve-month return on equity of 63.96%. When did Endologix's stock split? Endologix shares reverse split on the morning of Wednesday, March 6th 2019. The 1-10 reverse split was announced on Tuesday, March 5th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 5th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Endologix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Endologix investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH) and Gran Tierra Energy (GTE). This page (NASDAQ:ELGX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endologix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Endologix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.